Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Hematology ; 17 Suppl 1: S150-2, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22507806

RESUMEN

The von Willebrand factor (VWF) is analysed as a bleeding and thrombotic risk marker. When the VWF level is increased, it predicts a thrombotic phenotype and when VWF level is low in plasma, the phenotype varies to bleeding disorder. But it is quite challenging to define when the level is low, normal or high taking into account that these values are capricious and overlap. This matter should be solved by extensive epidemiologic studies. VWD is a hereditary disorder with several described mutations. VWF is a major acute-phase reactant, besides the physiological conditions such as blood group and pregnancy that affect plasmatic VWF levels. Subjects with O blood group have 25% less VWF than those of non O blood groups, and the latter show higher thrombus burden. VWF would be sensitive though not specific diagnostic marker of myocardial infarction. For the assessment of bleeding severity there are special surveys, scores and pictorial charts. The identification of VWF as a thrombotic risk marker has not been clearly established yet, but it has been involved in stroke and coronary disease. We only have the specific replacement therapy for the bleeding phenotype and we can speculate that enoxaparin and PEG-hirudin are able to blunt the VWF rise in patients with unstable angina pectoris and it is associated with a more favourable clinical outcome. Only two questions remain: does VWF as a bleeding risk marker have the same value as a thrombotic risk marker? Will successful treatments like those achieved for bleeding be also possible in the future for thrombosis?


Asunto(s)
Hemorragia/diagnóstico , Trombosis/diagnóstico , Factor de von Willebrand , Hemorragia/etiología , Humanos , Factores de Riesgo , Trombosis/etiología
2.
Blood Coagul Fibrinolysis ; 12(3): 207-9, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11414635

RESUMEN

Haemoperitoneum secondary to haemorrhagic corpus luteum has been described in severe bleeding disorders such as afibrinogenaemia, type 3 von Willebrand's disease and patients under oral anticoagulation. We have studied one patient who presented three episodes of severe bleeding at ovulation, requiring surgery twice, with the diagnosis of mild von Willebrand's disease and mild storage pool deficiency. Mild von Willebrand's disease (associated with other thrombopathies or coagulopathies) should be considered in this pathology, although physicians would prefer to find a severe haemorrhagic disorder as the underlying condition in these cases.


Asunto(s)
Cuerpo Lúteo/irrigación sanguínea , Hemoperitoneo/etiología , Ovulación , Deficiencia de Almacenamiento del Pool Plaquetario/complicaciones , Enfermedades de von Willebrand/complicaciones , Abdomen Agudo/etiología , Adulto , Pruebas de Coagulación Sanguínea , Epistaxis/etiología , Femenino , Hemorragia Gingival/etiología , Hematoma/etiología , Hemoperitoneo/cirugía , Humanos , Recurrencia , Choque/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA